Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis and a history of nonsteroidal immunosuppressant use: a post hoc analysis of the phase III CAFE trial

Bouaziz J-D., Ogg G., de Bruin-Weller M., Bieber T., Irvine A., Shumel B., Msihid J., Rossi AB.

Type

Conference paper

Publication Date

02/07/2019

Volume

181

Pages

66 - 67

Permalink